Intensive Insulin Therapy and Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Stroke Thrombolysis

Although post-thrombolysis hyperglycemia is associated with increased sICH risk, intensive therapy did not reduce this risk.

Baseline hyperglycemia is associated with an increased risk for symptomatic intracerebral hemorrhage (sICH) in patients receiving intravenous tPA for acute ischemic stroke. In this prespecified secondary analysis of data from the SHINE trial, investigators tested the hypothesis that intensive insulin therapy for hyperglycemia would reduce the risk for post-thrombolysis sICH as compared with standard glucose control. This analysis was based on the subset of 725 patients in SHINE (out of 1151 overall) that received intravenous thrombolysis for acute ischemic stroke. SHINE participants were randomized to intensive insulin therapy (continuous intravenous infusion; target glucose, 80–130 mg/dL) or standard glucose control (sliding scale subcutan…

Reviewing Author

Anthony S. Kim, MD

Disclosures

Grant/Research SupportNIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences

Anthony S. Kim, MD

Disclosures

Grant/Research SupportNIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences

Intensive Insulin Therapy and Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Stroke Thrombolysis

Topics

Reviewing Author